Serum Concentrations of Vitamin D, Calcium, Phosphorus and Trace Minerals in Adults and Children with Haemophilia A: Association with Disease Severity, Quality of Life, Joint Health and Functional Status
Background: To investigate the serum levels of 25(OH)D and minerals in adults and children with haemophilia A, and the possible association of these factors with Pediatric Haemophilia/Haemophilia Activities List (PedHAL/HAL), Haemophilia Joint Health Score (HJHS) and Haemophilia-specific quality of life (QoL) index this case-control study was conducted.
Materials and Methods: Eighty five haemophilia A patients (HP) registered in Hemophilia Society of Lorestan province were recruited. Along with HP, sex and age matched healthy controls (HCs) were recruited. Linear regression was used to evaluate the possible relation between biochemical factors and other variables. One-way analysis of variance (ANOVA) was used to compare the biochemical factors between three or more independent groups.
Results: Results indicated that serum zinc, phosphorus and magnesium were significantly lower, whereas, serum level of alkaline phosphatase (ALP) was statistically higher in HP compared with HCs. Other biochemical factors including calcium and parathyroid hormone (PTH) were not different between groups. Serum 25(OH) D was lower only in children with haemophilia and not in adults. Percentage of subjects who were vitamin D deficient was higher in HP vs. HCs (57.6% vs. 35.3%), and also this rate was higher in children with haemophilia vs. adults (77.8% vs. 48.3%). Lower serum concentrations of assessed minerals and vitamin D were associated with lower physical activity, poor QoL and worst joint health, and these associations were stronger in children.
Conclusion: Present study indicated that serum levels of vitamin D and minerals were low in HP, and these low levels were associated with poor QoL, lower physical activity and worst joint health.
1. Hoyer LW. Hemophilia a. N Engl J Med. 1994;330(1):38-47.
2. Gurcay E, Eksioglu E, Ezer U, et al. Functional disability in children with hemophilic arthropathy. Rheumatol Int. 2006;26(11):1031-5.
3. Kashyap R, Choudhry V. Management of hemophilia in developing countries. Indian J Hematol Blood Transfus. 2016; 32(3): 347–355.
4. Eshghi P, Mahdavi-Mazdeh M, Karimi M, et al. Haemophilia in the developing countries: the Iranian experience. Arch Med Sci. 2010; 6(1): 83–89.
5.Lafeber F, Miossec P, Valentino L. Physiopathology of haemophilic arthropathy. Haemophilia. 2008;14 Suppl 4:3-9.
6. Gerstner G, Damiano ML, Tom A, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia. 2009; 15 (2):559-65.
7. Assarehzadegan MA, Ghafourian Boroujerdnia M, Zandian K. Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran. Iran Red Crescent Med J. 2012; 14(8): 470–474.
8. duTreil S. Physical and psychosocial challenges in adult hemophilia patients with inhibitors. J Blood Med. 2014; 5:115-22.
9. Cheraghali AM, Eshghi P, Abolghasemi H. Social consequences of infected haemophilia cases in the Islamic Republic of Iran. East Mediterr Health J. 2011;17(6):552-6.
10. Ghanizadeh A, Baligh-Jahromi P. Depression, anxiety and suicidal behaviour in children and adolescents with Haemophilia. Haemophilia. 2009; 15 (2):528-32.
11. Mutlu M, Argun M, Kilic E, et al. Magnesium, zinc and copper status in osteoporotic, osteopenic and normal post-menopausal women. J Int Med Res. 2007;35(5):692-5.
12. Anagnostis P, Karras S, Paschou SA, et al. Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk. Blood Coagul Fibrinolysis. 2015;26(6):599-603.
13. Abdollahi A, Toogeh G, Gharechahi S, et al. Bone Structure-Related Biomarkers in Hemophilic Patients, Compared to Healthy Condition. Acta Medica Iranica 2018; 56 (3):166-169.
14. Gallacher SJ, Deighan C, Wallace AM, et al. Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study. Q J Med. 1994; 87(3):181-6.
15. Anagnostis P, Vakalopoulou S, Slavakis A, et al. Reduced bone mineral density in patients with haemophilia A and B in Northern Greece. Thromb Haemost. 2012;107(3):545-51.
16. Mahmoud Ghaniema E, Fathi Ahmed S, Raouf Amin I, et al. Evaluation of osteoporosis in hemophilic arthropathy patients: correlation with disease severity and serum trace minerals. J Osteoporos. 2011;2011:106380.
17. Arnold WD, Hilgartner M. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am. 1977; 59(3):287-305.
18. Hilliard P, Funk S, Zourikian N, et al. Hemophilia joint health score reliability study. Haemophilia. 2006; 12 (5):518-25.
19. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81.
20. Albayrak C, Albayrak D. Vitamin D levels in children with severe hemophilia A: an underappreciated deficiency. Blood Coagul Fibrinolysis. 2015; 26(3):285-9.
21. Katsarou O, Terpos E, Chatzismalis P, et al. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection. Ann Hematol. 2010; 89(1):67-74
22. Alioglu B, Selver B, Ozsoy H, et al. Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience. Haemophilia. 2012; 18 (1):69-74.
23. Eldash HH, Atwa ZT, Saad MA. Vitamin D deficiency and osteoporosis in hemophilic children: an intermingled comorbidity. Blood Coagul Fibrinolysis. 2017; 28(1):14-18.
24. Tlacuilo-Parra A, Morales-Zambrano R, Tostado-Rabago N, et al. Inactivity is a risk factor for low bone mineral density among haemophilic children. Br J Haematol. 2008; 140(5):562-7.
25. Mattsson A, Gross S. Social and behavioral studies on hemophilic children and their families. J Pediatr. 1966; 68 (6):952-964.
26. Backström MC, Kouri T, Kuusela AL, et al. Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr. 2000; 89(7):867-73.
27. Mutlu M, Argun M, Kilic E, et al. Magnesium, zinc and copper status in osteoporotic, osteopenic and normal post-menopausal women. J Int Med Res. 2007; 35(5):692-5.
28. Sahota O. Understanding vitamin D deficiency. Age Ageing. 2014; 43(5): 589–591.
29. Golden NH, Abrams SA, Committee on Nutrition. Optimizing bone health in children and adolescents. Pediatrics. 2014; 134(4):e1229-43.
30. Anglin RE, Samaan Z, Walter SD, et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013; 202:100-7.
31. Tahmasebi K, Amani R, Nazari Z, et al. Association of Mood Disorders with Serum Zinc Concentrations in Adolescent Female Students. Biol Trace Elem Res. 2017; 178(2):180-188.
32. Islam MR, Islam MR, Shalahuddin Qusar MMA, et al. Alterations of serum macro-minerals and trace elements are associated with major depressive disorder: a case-control study. BMC Psychiatry. 2018; 18: 94.
33. Stark D, Kiely M, Smith A, et al. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002; 20(14):3137-48.
34. Abbasnezhad A, Amani R, Hajiani E, et al. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Neurogastroenterol Motil. 2016; 28(10):1533-44.